Clinical trial
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia - A Prospective Observational Cohort Study - IBIS XLH
NCT07607600 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia - A Prospective Observational Cohort Study - IBIS XLH
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 7, 2026
- Completion date
- July 7, 2030
- Enrollment
- 0 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
x-linked hypophosphatemia (xlh)